Source: Private Equity Wire

Keyhaven: Keyhaven backs acquisition of HealthTech BioActives by Miura and Evolve

Keyhaven Capital Partners has partnered with Miura Partners and Evolve Healthcare Partners to support their acquisition of HealthTech BioActives, a global specialist in natural ingredients and active pharmaceutical production.

Read full article »
Keyhaven's Competitors | Keyhaven's News | Keyhaven's Financials
Stay up-to-date with the latest news on Keyhaven
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Claus Stenbaek's photo - Managing Partner of Keyhaven

Managing Partner

Claus Stenbaek

CEO Approval Rating

68/100

Read more
Stay up-to-date with the latest news on Keyhaven